Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Cardiovascular Institute of the South Is First in Baton Rouge to Use New Access Point for Impella Device Implant
12/03/2020
Cardiovascular Institute of the South (CIS) interventional cardiologists Drs. Niksad Abraham and Garland Green are the first in Baton Rouge to perform the first percutaneous Impella implant through a new axillary artery approach near the...
Cardiovascular Institute of the South (CIS) interventional cardiologists Drs. Niksad Abraham and Garland Green are the first in Baton Rouge to perform the first percutaneous Impella implant through a new axillary artery approach near the...
Cardiovascular Institute of the...
12/03/2020
Vascular Disease Management
News
MEDX Xelerator Approves New “X Lab” Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack
12/03/2020
MEDX Xelerator, an Israel-based medical device and digital health incubator, today announced the approval of its latest “X Lab” project focused on treating peripheral venous disease (PVD). The newly formed company, VeinWay, will be headed by...
MEDX Xelerator, an Israel-based medical device and digital health incubator, today announced the approval of its latest “X Lab” project focused on treating peripheral venous disease (PVD). The newly formed company, VeinWay, will be headed by...
MEDX Xelerator, an Israel-based...
12/03/2020
Vascular Disease Management
News
Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism
11/20/2020
Lightning 12 and Separator 12 Now Indicated for Treatment of PE
Lightning 12 and Separator 12 Now Indicated for Treatment of PE
Lightning 12 and Separator 12...
11/20/2020
Vascular Disease Management

Advertisement

News
VIVA Data Presentation: Zilver® Vena™ Venous Self-Expanding Stent Demonstrates Symptom Relief in Patients
11/17/2020
At this year’s Vascular Interventional Advances (VIVA) conference, Dr. Anthony Comerota presented data on the Zilver® Vena™ Venous Self-Expanding Stent that demonstrates durable patency and symptom relief in patients over an extended period...
At this year’s Vascular Interventional Advances (VIVA) conference, Dr. Anthony Comerota presented data on the Zilver® Vena™ Venous Self-Expanding Stent that demonstrates durable patency and symptom relief in patients over an extended period...
At this year’s Vascular...
11/17/2020
Vascular Disease Management
News
Control Medical and TZ Medical Announce Exclusive U.S. Distribution Agreement
11/16/2020
Control Medical and TZ Medical announced an exclusive distribution agreement for the United States for the Control Medical Mechanical Thrombectomy System.
Control Medical and TZ Medical announced an exclusive distribution agreement for the United States for the Control Medical Mechanical Thrombectomy System.
Control Medical and TZ Medical...
11/16/2020
Vascular Disease Management
News
New XO Score Angioplasty System Dilates Calcified and Fibrotic Vessels
11/16/2020
The new FDA-cleared XO Score® system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas.
The new FDA-cleared XO Score® system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas.
The new FDA-cleared XO Score®...
11/16/2020
Vascular Disease Management

Advertisement

News
medQ Signs New Strategic Partnership Agreement with Shina Systems
11/16/2020
medQ Inc, a leading provider of automated imaging workflow solutions, has signed a strategic partnership agreement with Shina Systems Ltd., a market leader in imaging applications and AI open platform PACS solutions.
medQ Inc, a leading provider of automated imaging workflow solutions, has signed a strategic partnership agreement with Shina Systems Ltd., a market leader in imaging applications and AI open platform PACS solutions.
medQ Inc, a leading provider of...
11/16/2020
Vascular Disease Management
News
Cardiovascular Institute of the South (CIS) Is Only Facility in Louisiana to Earn National Recognition This Year for Blood Pressure Control
11/16/2020
Cardiovascular Institute of the South is the only facility in Louisiana that has been awarded Gold Status by the American Heart Association and the American Medical Association for its commitment to keeping patient blood pressure rates under...
Cardiovascular Institute of the South is the only facility in Louisiana that has been awarded Gold Status by the American Heart Association and the American Medical Association for its commitment to keeping patient blood pressure rates under...
Cardiovascular Institute of the...
11/16/2020
Vascular Disease Management
News
New Xarelto (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
11/11/2020
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new...
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new...
The Janssen Pharmaceutical...
11/11/2020
Vascular Disease Management

Advertisement

News
Ticagrelor Approved in the U.S. to Reduce Risk of Stroke in Patients With Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
11/11/2020
AstraZeneca’s BRILINTA® (ticagrelor) has been approved in the U.S. to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5)...
AstraZeneca’s BRILINTA® (ticagrelor) has been approved in the U.S. to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5)...
AstraZeneca’s BRILINTA®...
11/11/2020
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use